Xiaowei Xing

416 total citations
13 papers, 331 citations indexed

About

Xiaowei Xing is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Nephrology. According to data from OpenAlex, Xiaowei Xing has authored 13 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Pathology and Forensic Medicine and 3 papers in Nephrology. Recurrent topics in Xiaowei Xing's work include Traditional Chinese Medicine Analysis (3 papers), Chronic Kidney Disease and Diabetes (3 papers) and MicroRNA in disease regulation (2 papers). Xiaowei Xing is often cited by papers focused on Traditional Chinese Medicine Analysis (3 papers), Chronic Kidney Disease and Diabetes (3 papers) and MicroRNA in disease regulation (2 papers). Xiaowei Xing collaborates with scholars based in China. Xiaowei Xing's co-authors include Qinghua Lu, Jing Guo, Yimeng Du, Guanghao Zhang, Shuang Guo, Chunyan Wang, Yanwu Jin, Na Lv, Ping Liu and Caixia Liu and has published in prestigious journals such as Scientific Reports, Biomedicine & Pharmacotherapy and Drug Delivery.

In The Last Decade

Xiaowei Xing

13 papers receiving 326 citations

Peers

Xiaowei Xing

CCM

PFM

SURGE

Nana He China

Xuejie Wu China

Wenping Lü China

Shahriar Hashemzadeh Iran

Emeli Chatterjee United States

Caixia Lin China

Jingyuan Mao China

Xiufeng Zheng China

Nana He China

Xiaowei Xing

290 ×1.8

115 ×1.4

57 ×0.9

CCM

37 ×0.7

PFM

55 ×1.7

SURGE

Citations per year, relative to Xiaowei Xing Xiaowei Xing (= 1×) peers Nana He

Countries citing papers authored by Xiaowei Xing

Since Specialization

Citations

This map shows the geographic impact of Xiaowei Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowei Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowei Xing more than expected).

Fields of papers citing papers by Xiaowei Xing

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaowei Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowei Xing. The network helps show where Xiaowei Xing may publish in the future.

Co-authorship network of co-authors of Xiaowei Xing

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaowei Xing. A scholar is included among the top collaborators of Xiaowei Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaowei Xing. Xiaowei Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Jiang, Shan, et al.. (2024). Hsa_circ_0081065 exacerbates IH-induced EndMT via regulating miR-665/HIF-1α signal axis and HIF-1α nuclear translocation. Scientific Reports. 14(1). 904–904. 4 indexed citations

Xing, Xiaowei, et al.. (2023). Astragaloside IV ameliorates insulin induced insulin resistance in HepG2 cells through reactive oxygen species mediated c-Jun N-terminal kinase pathway.. PubMed. 43(1). 60–67. 3 indexed citations

Guo, Jing, et al.. (2022). Acute myocardial infarction therapy using calycosin and tanshinone co-loaded; mitochondrion-targeted tetrapeptide and cyclic arginyl-glycyl-aspartic acid peptide co-modified lipid-polymer hybrid nano-system: preparation, characterization, and anti myocardial infarction activity assessment. Drug Delivery. 29(1). 2815–2823. 9 indexed citations

Xing, Xiaowei, Shuang Guo, Jiangying Kuang, et al.. (2021). Saxagliptin protects against diabetic nephropathy by inhibiting caspase 3/PARP‑1‑dependent nephrocyte apoptosis. Experimental and Therapeutic Medicine. 22(3). 990–990. 5 indexed citations

Zhang, Weihao, et al.. (2021). The effect of flipped classroom in multiple clinical skills training for clinical interns on Objective Structured Clinical Examinations (OSCE). Medical Education Online. 27(1). 2013405–2013405. 17 indexed citations

Xing, Xiaowei, et al.. (2020). miR-26a-5p protects against myocardial ischemia/reperfusion injury by regulating the PTEN/PI3K/AKT signaling pathway. Brazilian Journal of Medical and Biological Research. 53(2). e9106–e9106. 88 indexed citations

Zhao, Tong, Fei Xu, Juan Wang, et al.. (2019). Liraglutide alleviates cardiac fibrosis through inhibiting P4hα-1 expression in STZ-induced diabetic cardiomyopathy. Acta Biochimica et Biophysica Sinica. 51(3). 293–300. 20 indexed citations

Guo, Jing, et al.. (2019). Therapy for myocardial infarction: In vitro and in vivo evaluation of puerarin-prodrug and tanshinone co-loaded lipid nanoparticulate system. Biomedicine & Pharmacotherapy. 120. 109480–109480. 25 indexed citations

Guo, Jing, et al.. (2017). RGD modified and PEGylated lipid nanoparticles loaded with puerarin: Formulation, characterization and protective effects on acute myocardial ischemia model. Biomedicine & Pharmacotherapy. 89. 297–304. 86 indexed citations

10.

Wang, Chunyan, et al.. (2015). Correlation between serum exosome derived miR-208a and acute coronary syndrome.. PubMed. 8(3). 4275–80. 54 indexed citations

11.

Liu, Ping, et al.. (2014). Clinical analysis of the relationship between cystatin C and metabolic syndrome in the elderly. Revista Portuguesa de Cardiologia. 33(7-8). 411–416. 16 indexed citations

12.

Liu, Ping, et al.. (2013). [Association of Cystatin C and metabolic syndrome].. PubMed. 93(40). 3207–10. 1 indexed citations

13.

Jiang, Tiebin, Xin Li, Jun Zhou, et al.. (2008). [Expression of PDCD5 in multiple myeloma and its relation with BCL-2].. PubMed. 33(9). 814–20. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nana He Breakdown of academic impact, for papers by Xuejie Wu Breakdown of academic impact, for papers by Wenping Lü Breakdown of academic impact, for papers by Shahriar Hashemzadeh Breakdown of academic impact, for papers by Emeli Chatterjee Breakdown of academic impact, for papers by Caixia Lin Breakdown of academic impact, for papers by Jingyuan Mao Breakdown of academic impact, for papers by Xiufeng Zheng